113 related articles for article (PubMed ID: 21913991)
1. Immunoexpression of TNF-α and TGF-β in central and peripheral giant cell lesions of the jaws.
de Matos FR; de Moraes M; Nonaka CF; de Souza LB; de Almeida Freitas R
J Oral Pathol Med; 2012 Feb; 41(2):194-9. PubMed ID: 21913991
[TBL] [Abstract][Full Text] [Related]
2. NFATc1 and TNFalpha expression in giant cell lesions of the jaws.
Amaral FR; Brito JA; Perdigão PF; Carvalho VM; de Souza PE; Gomez MV; De Marco L; Gomez RS
J Oral Pathol Med; 2010 Mar; 39(3):269-74. PubMed ID: 20002873
[TBL] [Abstract][Full Text] [Related]
3. Immunoexpression of Glucose Transporters 1 and 3 and Macrophage Colony-Stimulating Factor in Central and Peripheral Giant Cell Lesions of the Jaws.
Vasconcelos RG; de Matos FR; Vasconcelos MG; da Costa AN; Queiroz LM
J Oral Maxillofac Surg; 2016 May; 74(5):965-72. PubMed ID: 26706492
[TBL] [Abstract][Full Text] [Related]
4. Immunoexpression of MMP-9, VEGF, and vWF in central and peripheral giant cell lesions of the jaws.
Matos FR; Nonaka CF; Miguel MC; Galvão HC; de Souza LB; Freitas Rde A
J Oral Pathol Med; 2011 Apr; 40(4):338-44. PubMed ID: 21198871
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of p53, PCNA, Ki-67, MDM2 and AgNOR in oral peripheral and central giant cell lesions.
Souza PE; Mesquita RA; Gomez RS
Oral Dis; 2000 Jan; 6(1):35-9. PubMed ID: 10673786
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of RANKL in oral giant cell lesions is predictive of aggressiveness.
Martini G; Capella D; Rivero ERC; Gondak RO
Braz Oral Res; 2018 Oct; 32():e115. PubMed ID: 30379236
[TBL] [Abstract][Full Text] [Related]
7. FASN expression, angiogenesis and lymphangiogenesis in central and peripheral giant cell lesions.
Falci SG; Mesquita AT; Andrade BA; Miranda JL; Leon JE; Almeida OP; Santos CR
J Appl Oral Sci; 2014 Apr; 22(2):131-7. PubMed ID: 24676584
[TBL] [Abstract][Full Text] [Related]
8. WWOX expression in giant cell lesions of the jaws.
Amaral FR; Diniz MG; Bernardes VF; Souza PE; Gomez RS; Gomes CC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):210-3. PubMed ID: 23849374
[TBL] [Abstract][Full Text] [Related]
9. Quantitative expression analysis of apoptotic/antiapoptotic genes and association with immunolocalization of BAX and BCL-2 in peripheral and central giant cell lesions of the jaws.
Amaral FR; Bernardes VF; Duarte AP; Pereira NB; Vasconcelos AC; Gomez RS; Gomes CC
Tumour Biol; 2011 Oct; 32(5):997-1003. PubMed ID: 21706237
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone-related peptide (PTHrP), parathyroid hormone/parathyroid hormone-related peptide receptor 1 (PTHR1), and MSX1 protein are expressed in central and peripheral giant cell granulomas of the jaws.
Houpis CH; Tosios KI; Papavasileiou D; Christopoulos PG; Koutlas IG; Sklavounou A; Alexandridis C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):415-24. PubMed ID: 20060342
[TBL] [Abstract][Full Text] [Related]
11. Systemic leukocyte activation in patients with central giant cell lesions.
de Souza PE; Gomez RS; Xavier GM; dos Santos JS; Gollob KJ; Dutra WO
J Oral Pathol Med; 2005 May; 34(5):312-7. PubMed ID: 15817076
[TBL] [Abstract][Full Text] [Related]
12. Peri-implant peripheral giant cell lesions: report of 13 new cases and comparative histological and immunohistochemical analysis with peripheral and central giant cell lesions.
Morais TM; Soares CD; Aguirre Urizar JM; Alberdi-Navarro J; Almeida OP; Pires FR
Med Oral Patol Oral Cir Bucal; 2019 Nov; 24(6):e739-e745. PubMed ID: 31655833
[TBL] [Abstract][Full Text] [Related]
13. Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization.
Boldrini L; Calcinai A; Samaritani E; Pistolesi F; Mussi A; Lucchi M; Angeletti CA; Basolo F; Fontanini G
Br J Cancer; 2000 Aug; 83(4):480-6. PubMed ID: 10945495
[TBL] [Abstract][Full Text] [Related]
14. IL-10 and IL-10 receptor overexpression in oral giant cell lesions.
Syrio NF; Faria DR; Gomez RS; Gollob KJ; Dutra WO; Souza PE
Med Oral Patol Oral Cir Bucal; 2011 Jul; 16(4):e488-92. PubMed ID: 21196886
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.
Quinn JM; Itoh K; Udagawa N; Hausler K; Yasuda H; Shima N; Mizuno A; Higashio K; Takahashi N; Suda T; Martin TJ; Gillespie MT
J Bone Miner Res; 2001 Oct; 16(10):1787-94. PubMed ID: 11585342
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor alpha enhances secretion of transforming growth factor beta2 in MCF-7 breast cancer cells.
Danforth DN; Sgagias MK
Clin Cancer Res; 1996 May; 2(5):827-35. PubMed ID: 9816237
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 expression in central giant cell lesion of the jaws: an immunohistochemical study.
Nogueira RL; Faria MH; Osterne RL; Cavalcante RB; Ribeiro RA; Rabenhorst SH
J Mol Histol; 2012 Feb; 43(1):59-62. PubMed ID: 22042094
[TBL] [Abstract][Full Text] [Related]
18. Giant cell lesions of the jaws: does the level of vascularity and angiogenesis correlate with behavior?
Peacock ZS; Jordan RC; Schmidt BL
J Oral Maxillofac Surg; 2012 Aug; 70(8):1860-6. PubMed ID: 22104131
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of transforming growth factor beta signaling in MCF-7 cells results in resistance to tumor necrosis factor alpha: a role for Bcl-2.
Tobin SW; Brown MK; Douville K; Payne DC; Eastman A; Arrick BA
Cell Growth Differ; 2001 Feb; 12(2):109-17. PubMed ID: 11243465
[TBL] [Abstract][Full Text] [Related]
20. Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration.
Zheng MH; Fan Y; Wysocki SJ; Lau AT; Robertson T; Beilharz M; Wood DJ; Papadimitriou JM
Am J Pathol; 1994 Nov; 145(5):1095-104. PubMed ID: 7977641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
